Page results
-
Information about the use of deferasirox iron chelation treatment for iron overload.
-
UCLH is the first NHS centre in the UK to offer patients suffering from obstructive sleep apnœa (OSA) a choice of nerve stimulation devices to manage their condition.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the neck, chest, abdomen, and pelvis.
-
This page is for parents and carers whose child is having radiotherapy treatment to the neck and chest.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the abdomen.
-
This page is to help prepare you and the family for your child’s radiotherapy treatment under a general anaesthetic.
-
This page is for parents and carers whose child is having radiotherapy treatment to a limb (arm or leg).
-
This step-by-step guide explains how you can give yourself an injection of bortezomib at home.
-
This information has been written for parents and carers whose child is having radiotherapy treatment to the whole lungs. The page explains the side effects your child may experience during and after treatment, and how best to cope with them.
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
File results
-
FOI/2023/0352 - Data security training, data breach reporting, security budgets
-
FOI/2023/0345 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer
-
FOI/2023/0344 - Number of neonatal and stillbirth deaths since January 2013
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care
-
FOI/2023/0342 - Self-administration of medication policies
-
FOI/2023/0337 - Trac systems e-recruitment software used at the Trust
-
FOI/2023/0336 - Number of pagers currently in use at the Trust
-
FOI/2023/0330 - Outsourced/ in-house occupational health provisions
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology